Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators.
Michela CapraroMarco PedrazziRoberta De TullioMarcello ManfrediFederico CrestaCarlo CastellaniMonica AvernaPublished in: International journal of molecular sciences (2023)
. This knowledge could be helpful for future studies of personalized medicine and thereby ensure improvements in individual responses to therapies.